About

African Beauty Intelligence is an editorial and intelligence platform focused on one question that gets answered badly almost everywhere else: what actually works for hyperpigmentation on melanin-rich skin, and how do we know?

The problem

The skincare conversation for African women is dominated by three problems. Marketing claims get repeated as though they were findings. Search-result snippets get cited as though someone had read the paper. And ingredient-level evidence for a prescription strength gets quietly transferred to whatever the shelf actually stocks.

None of that is the fault of readers. It is a failure of the information supply chain — and it is fixable.

What we do differently

Every clinical statement we publish is linked to the source it came from. We keep the original research labels because they are the most honest way to say what we actually did with each one:

Read in full — the page was opened and the value was taken from what we actually read. These are the ones our claims rest on.
Lead only — a search result we have not opened yet. It points us somewhere; it does not carry a claim.
Checked, not confirmed — we went looking and could not confirm the value, so it stays out of the argument.
Not researched yet — work outstanding. We say so rather than filling the gap.

Evidence categories follow the same discipline. Scientific evidence, clinical consensus, consumer experience, social-media popularity, marketing claims and our own inference are six different things, and we never blur them. Consumer experience is valuable — but it is not a clinical trial.

Who this is for

African women aged roughly 25 to 45 across Kenya, Nigeria, South Africa and Ghana, and readers in the diaspora who want the same rigour applied to melanin-rich skin. We also serve the diaspora and international readers who search for evidence-based guidance on pigmentation.

What we will never do

Publish a medical claim without a source that was actually read.
Present a brand's marketing language as if it were a finding.
Invent a price, a creator metric, a demographic or a statistic.
Transfer evidence for an ingredient at one concentration to a product at another.
Recommend prescription or medically supervised treatments casually — or at all without supervision.
Claim a clinician reviewed our work when they did not.
Rank a product as clinically superior because it pays us.

Where we are now

This platform launched from a structured research checkpoint, and it is honest about what that checkpoint does and does not contain. Some modules are complete; others were never collected. The research library shows exactly which is which, and the coverage gaps are named rather than papered over.

Commercial model

The audience comes first. We will use affiliate relationships where they exist, and they are always disclosed — see the affiliate disclosure. An affiliate link never changes an evidence rating, and a product is never presented as clinically superior because a commission changes when you buy it. Where no affiliate relationship exists, we say so plainly rather than inventing one.

Corrections

Research changes, and so does this site. The research checkpoint already documents at least one correction — an earlier finding that azelaic acid was unavailable in Nigeria turned out to be an artifact of searching the wrong collection page, not a market condition. When we get something wrong we correct it in the open, with the reasoning. Get in touch if you spot something that does not hold up.

Standards we work to

Editorial standards · Evidence and research methodology · Medical disclaimer